Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
Yi Shi reported a 11.10% stake in Adarx Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 16, 2026
Yi Shi reported a 11.10% stake in Adarx Pharmaceuticals, Inc., 11,858,655 shares, as a passive investor on Sep 30, 2026. Filed Oct 16, 2026 (Schedule 13G).
- Stake
- 11.10%
- Shares
- 11,858,655
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LAV Biosciences Fund V, L.P. | 10.50% | 11,243,179 |
| LAV Fund VI, L.P. | 0.30% | 307,738 |
| LAV Fund VI Opportunities, L.P. | 0.30% | 307,738 |
| Yi Shi | 11.10% | 11,858,655 |
Source
Download original · View original at SEC
Related
- Adarx Pharmaceuticals, Inc.
- Yi Shi
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026
- Form 4 · Gordon Carl L · Sep 30, 2026